| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2007;134:297-303
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Pediatrics, Division of Cardiology, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
b Department of Surgery, Division of Cardiothoracic Surgery, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
c Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa
d Department of Pediatrics, Division of Cardiology, Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Received for publication February 1, 2007; accepted for publication February 21, 2007. * Address for reprints: Jean Ballweg, MD, Cardiac Intensive Care Unit, The Children’s Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19119. (Email: ballweg{at}email.chop.edu).
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Methods: We retrospectively reviewed the echocardiograms, catheterizations, and hospital records of all patients who had a stage 1 reconstruction between January 2002 and May 2005 and performed a cross-sectional analysis of hospital survivors.
Results: One hundred seventy-six patients with hypoplastic left heart syndrome and variants underwent a stage 1 reconstruction with either a right ventricle–pulmonary artery conduit (n = 62) or a modified Blalock–Taussig shunt (n = 114). The median duration of follow-up is 29.1 months (range, 0-57 months). By means of Kaplan–Meier analysis, there is no difference in survival at 3 years (right ventricle–pulmonary artery conduit: 73% [95% confidence limit, 59%–83%] vs modified Blalock–Taussig shunt: 69% [95% confidence limit, 59%–77%]; P = .6). One hundred twenty-four patients have undergone stage 2 reconstruction (78 modified Blalock–Taussig shunts and 46 right ventricle–pulmonary artery conduits). At the time of the stage 2 reconstruction, patients with right ventricle–pulmonary artery conduits were younger (153 days [range, 108–340 days]; modified Blalock–Taussig shunt, 176 days [range, 80–318 days]; P = .03), had lower systemic oxygen saturation (73% [range, 58%–85%] vs 77% [range, 57%–89%], P < .01), and had higher preoperative hemoglobin levels (15.8 g/dL [range, 13–21 g/dL] vs 14.8 g/dL [range, 12–19 g/dL], P < .01) compared with those of the modified Blalock–Taussig shunt group. By means of echocardiographic evaluation, there was a higher incidence of qualitative ventricular dysfunction in patients with right ventricle–pulmonary artery conduits (14/46 [31%] vs 9/73 [12%], P = .02). However, no difference was observed in common atrial pressure or the arteriovenous oxygen difference.
Conclusion: Interim analyses suggest no advantage of one shunt type over another. This report raises concern of late ventricular dysfunction and outcome in patients with a right ventricle–pulmonary artery conduit.
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the absence of transplantation, hypoplastic left heart syndrome (HLHS) and its variants require staged surgical reconstruction to palliate the anatomic abnormalities. Stage 1 reconstruction (S1R) includes aortic arch reconstruction, anastomosis of the proximal main pulmonary artery with the ascending aorta, ligation of the distal main pulmonary artery, atrial septectomy, and provision of a source of pulmonary blood flow. Recently, an alternative strategy to S1R has become popularized: replacing the modified Blalock–Taussig shunt (mBTS) with a right ventricle–pulmonary artery (RV-PA) conduit as the source of pulmonary blood flow.1 The theory behind this modification is that the use of the RV-PA conduit will result in less diastolic runoff into the pulmonary vasculature and therefore improved coronary and myocardial perfusion. Several case series using the mBTS as a historical control have documented improved S1R early outcome with the use of the RV-PA conduit.2-6 However, other case series using both contemporary and historical controls have not found significant differences in early survival with the use of the RV-PA conduit.7-9 Most recently, contemporary comparison of the immediate hemodynamics after S1R with both shunt types in a randomized study did not demonstrate benefit of one shunt type versus the other.10
Using contemporary controls, we recently demonstrated no difference in surgical mortality, time to extubation, or length of hospital stay in 149 infants undergoing S1R for HLHS or variants palliated with either an mBTS or an RV-PA conduit.8 We undertook the current study to compare the midterm hemodynamics and outcomes for the 2 shunt strategies at stage 2 reconstruction (S2R). The current study objectives include defining the difference between the 2 shunt groups with regard to (1) preoperative hemodynamic parameters, as defined by cardiac catheterization and echocardiography; (2) angiographic pulmonary artery size and architecture at the S2R; (3) age and degree of illness (as defined by anticongestive medication use, use of home oxygen, and tube feedings) at the time of S2R; and (4) stage 2 morbidity and mortality.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We reviewed the initial, pre-S2R and pre–stage 3 reconstruction (S3R) echocardiographic reports of the study patients. Qualitative measurements of systolic ventricular function, atrioventricular valve regurgitation (AVVR), and neoaortic valve regurgitation were recorded.
Oximetry, hemodynamic, and angiographic data were obtained at cardiac catheterization before S2R after achievement of conscious sedation or general anesthesia. Measured data included venous and arterial saturations, common atrial pressure, pulmonary artery pressure or pulmonary venous wedge pressure, and aortic pressure. Calculated data included arteriovenous oxygen difference and coronary perfusion pressure. Angiographic measurements were obtained from the anteroposterior or anterior oblique projections offline by a single observer to assess branch pulmonary artery anatomy and growth. The Nakata index was calculated as previously described.11 The narrowest portion of the proximal branch pulmonary artery within 1 cm of the shunt insertion was measured by using standard offline techniques and compared with the vessel diameter just before the take-of the lobar branches to assess pulmonary artery stenosis. The ratio of these 2 measurements was used as a measure of severity of pulmonary artery stenosis and was graded as follows: moderate-to-severe stenosis, ratio less than 0.65; mild stenosis, ratio 0.66 to 0.85; and no stenosis, ratio greater than 0.85. The appearance of the branch pulmonary arteries was also recorded to ascertain the degree of pulmonary artery distortion qualitatively. The appearance was graded as follows: normal, diffusely narrowed, or discretely narrowed at the shunt or conduit insertion.
The operative technique for S1R has been previously described.8 There was a surgical preference for the use of the RV-PA conduit in aortic atresia and the mBTS for lesions with a single left ventricle (Table 1). S2R consisted of either a bidirectional Glenn or hemi-Fontan procedure. Patients with bilateral superior vena cavae underwent either the bilateral bidirectional Glenn procedure or the right hemi-Fontan and left bidirectional Glenn procedure. The selection of a bidirectional Glenn or hemi-Fontan procedure was at the discretion of the surgeon. Patients with heterotaxy syndrome with interrupted inferior vena cavae underwent the Kawashima procedure. Additional procedures, such as tricuspid valve annuloplasty or valvuloplasty, were documented. Age and size at S2R and comparative operative data, including additional cardiac operative procedures performed, cardiopulmonary bypass time, aortic crossclamp time, and deep hypothermic circulatory arrest (DHCA) time, were recorded. Postoperative data, including total length of intubation, incidence of reintubation, and cardiac intensive care unit and hospital lengths of stay, were also recorded. Need for extracorporeal membrane oxygenation, cardiopulmonary resuscitation, reoperation, or cardiac catheterization before discharge or listing for transplantation were documented. Other perioperative morbid events, including placement of chest tubes, postoperative seizures, and wound infections, were documented. The incidence of rehospitalization was obtained to assess the postdischarge morbidity. The indications for admission, length of stay, invasive procedures performed, and outcome were ascertained from the medical records or from the parents directly. Other operative procedures, including bronchoscopy, tracheostomy, and gastrostomy tube placement, were documented as well.
|
2 analyses were used for dichotomous and categoric variables. Kaplan–Meier survival curves using a composite end point of death or transplantation were stratified by shunt type. All data were analyzed by using STATA 8.0 software (STATA Corp, College Station, Tex). |
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
.01). Anatomic subtypes are described in Table 1. Surgical mortality (death at less than 30 days postoperatively or before hospital discharge) was similar between the 2 groups (mBTS, 20/114; RV-PA, 10/62; P = .81) for S1R. Of the 146 S1R survivors, 124 have undergone S2R (mBTS, 78/94; RV-PA, 46/52; P = .33). Four patients have undergone other palliative procedures (mBTS, 2/94; RV-PA, 2/52; P = .74), and 1 patient is awaiting S2R (Figure 1). Other palliative procedures included transplantation and additional shunt placement. Interstage death, defined as death after hospital discharge from S1R but before S2R, accounts for the remaining 17 patients. No significant difference in the incidence of interstage death between shunt types (mBTS, 13/94; RV-PA, 4/52; P = .4) was found.
|
|
Preoperative Cardiac Catheterization Data
There were consistent and significant differences in aortic saturation, diastolic arterial pressure, and coronary perfusion pressure between shunt types at the pre-S2R catheterization (Table 3). There was no significant difference between the 2 groups with respect to mixed systemic venous saturation obtained in the superior vena cava, arteriovenous oxygen difference, common atrial pressure, or pulmonary artery pressure (Table 3). The calculated Qp/Qs ratio was significantly higher in those patients with an mBTS (mBTS, 1.7 ± 0.86; RV-PA, 1.3 ± 0.69; P = .025).
|
There were 5 deaths (1 surgical and 4 nonsurgical) in the RV-PA conduit group and 4 deaths (3 surgical and 1 nonsurgical) in the mBTS group after S2R (P = .47). A total of 4 patients were listed for heart transplantation after S2R, 3 in the RV-PA group and 1 in the mBTS group. Of the 3 from the RV-PA group, 2 underwent transplantation and 1 died of sepsis while listed for transplantation.
S2R Morbidity
S2R consisted of the bidirectional Glenn or hemi-Fontan procedure for all, with the exception of 3 patients who underwent the Kawashima procedure and 12 patients who underwent bilateral bidirectional Glenn or right sided hemi-Fontan and left bidirectional Glenn procedures because of bilateral superior vena cavae. Ten patients underwent tricuspid valvuloplasty at the time of S2R (mBTS, 4/73; RV-PA, 6/46; P = .27). Cardiopulmonary bypass, crossclamp, and DHCA times for S2R were not statistically different between shunt types. DHCA was used in 63% of the patients (mBTS, 41/73; RV-PA, 34/46; P = .08).
There was no difference in the time to initial extubation, with the majority of the patients in both groups extubated on the day of surgical intervention. Seven patients in the mBTS group failed the first attempted extubation in comparison with 2 patients in the RV-PA group. There was no difference in the intensive care unit or hospital length of stay after S2R between groups (Table 4). Pleural effusion requiring chest tube placement occurred in 4 patients in the RV-PA group and 12 patients in the mBTS group during the surgical hospitalization. A total of 9 patients underwent cardiac catheterization before discharge. Of those with prior RV-PA conduits, 2 of the 5 patients underwent hemodynamic studies only, and 4 underwent pulmonary artery angioplasty or placement of a stent within 1 or both pulmonary arteries. Aortopulmonary collateral arteries were coil occluded in 2 patients and a venous decompressing vein was coil occluded in 1 patient in the mBTS group. Other morbidities included the use of extracorporeal membrane oxygenation with subsequent decannulation and listing for heart transplantation in 1 patient in the mBTS group, 9 patients with seizures postoperatively, 9 patients with superficial or deep wound infection (Table 4), and 1 patient in the mBTS group with alanine and aspartate aminotransferase levels of greater than 1000 mg/dL.
|
The median length of follow-up is 29.1 months and is not different between groups. Overall survival and freedom from death or transplantation by means of Kaplan–Meier analysis are no different between groups (Figure 2). To date, 58 patients have subsequently undergone S3R (mBTS, 40/78; RV-PA, 18/46). There have been 2 deaths after S3R, both in the mBTS group. As determined by means of echocardiography at the time of S3R, ventricular function was moderately or severely decreased in 11% of patients who initially underwent S1R with an RV-PA conduit in comparison with 2.5% of patients who had an mBTS at S1R (mBTS, 1/40; RV-PA, 2/18; P = .3). Significant AVVR and neoaortic regurgitation tended to be more common in patients in the RV-PA conduit group compared with in the mBTS group (AVVR: mBTS, 8/40; RV-PA, 8/18; P = .1; neoaortic regurgitation: mBTS, 3/40; RV-PA, 5/18; P = .1). Of all patients currently alive, 34% receive ancillary services, such as occupational, physical, or speech therapy, and 33% have gross motor delays, speech delays, or both, as reported by parents. Thirty-five percent of this same cohort routinely requires evaluation by other subspecialists, including neurology, otolaryngology, gastroenterology, and general surgery. The use of ancillary services is similar between shunt types.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The most recent modification is the use of an RV-PA conduit. This technique was first described by Norwood and colleagues18 in the early 1980s but was abandoned in favor of a systemic to pulmonary shunt. Multiple centers have reported improved surgical survival with the use of this conduit when compared with historical controls.1,5
Hemodynamic evaluation outside of the immediate postoperative period of infants undergoing S1R with an RV-PA conduit has been limited. Maher and associates19 recently described the comparative hemodynamic profiles of 24 infants before S2R. This study demonstrated higher aortic diastolic pressure, higher coronary perfusion pressure, and larger pulmonary arteries in those patients who underwent reconstruction with an RV-PA conduit.19 Januszewska and coworkers20 demonstrated increased pulmonary artery size in patients with an RV-PA conduit when evaluated echocardiographically or intraoperatively at the time of S2R for a consecutive series of 78 patients who had undergone S1R with either an mBTS or RV-PA conduit for HLHS.
Midterm and long-term ventricular performance is also a concern in those patients who undergo S1R with an RV-PA conduit because of the need for a ventricular incision at the time of conduit placement. Tanoue and associates21 describe comparable ventricular performance, as assessed by means of echocardiography, at the time of S2R between shunt types; however, after the S2R and total cavopulmonary connection (S3R), ventricular contractility was found to be inferior in those with an RV-PA conduit. Others describe improved early ventricular function in patients with RV-PA conduit, as assessed by means of strain Doppler echocardiography.22
In the current study infants with an RV-PA conduit were younger and more hypoxemic at the time of S2R. They were the same weight with less pulmonary blood flow, resulting in a more balanced systemic and pulmonary blood flow with a comparative degree of medically treated heart failure as those infants with an mBTS. The differences between shunt types did not appear to affect S2R hospitalization or interstage death. The more balanced Qp/Qs ratio and increased hypoxemia is consistent with that of others routinely using a 5-mm RV-PA conduit.2-4,6 In our cohort less pulmonary blood flow might be a result of more distortion of the pulmonary arteries, as well as a smaller right pulmonary artery within this group as a whole.
Little is known about changes in pulmonary architecture with the use of the RV-PA conduit. Asymmetric pulmonary artery growth with left pulmonary artery narrowing has been previously described.23 In the current study the pulmonary arteries at the time of S2R catheterization appeared "tented," or pulled forward, as the RV-PA conduit inserted to the left of the neoaorta into the confluence of the branch pulmonary arteries. This tenting resulted in a significant amount of narrowing of the branch pulmonary arteries at the insertion point. This is supported by a recent report comparing the shunt types of patients undergoing S1R with use of both shunt types.24 Stenoses were found to be more severe, causing significant reduction in the pulmonary artery dimension in those patients who had an RV-PA conduit.24 In the current comparative study the positioning of the shunt also appears to have influenced pulmonary artery size, resulting in preferential blood flow to the left pulmonary artery.
There are limited data available on the effect of an incision in the single right ventricle for the placement of an RV-PA conduit on systemic ventricular function. We found, by means of echocardiographic assessment, that patients with an RV-PA conduit at S1R had more ventricular dysfunction at the time of S2R. These infants had ventricular dysfunction during the interstage time interval because they had normal ventricular function at the time of initial presentation and the time of hospital discharge after S1R. Tanoue and associates21 evaluated the ventricular performance (as assessed by means of evaluation of contractility), afterload, and ventricular efficiency in a group of patients with HLHS who had undergone complete staged repair. Midterm or pre-S2R assessment was that there was no difference in ventricular efficiency; however, after S2R and S3R, contractility in patients who had previously undergone palliation at the time of S1R with an RV-PA conduit was inferior to that of patients who underwent S1R with a mBTS.21 The role of afterload reduction was underscored in this study because contractility might have decreased, but ventricular efficiency remained unchanged because the afterload of the ventricle had also been reduced. Nearly 80% of patients treated with an RV-PA conduit at S1R are currently on afterload reduction compared with 50% of patients with an mBTS.
Survival was similar between shunt types at a median of 29 months’ follow-up. It is plausible to postulate that although there is improved coronary perfusion between S1R and S2R that might be protective in regard to interstage death, its effect on long-term protection of ventricular function might not be enough to overcome the effects of the ventricular incision.
This study is limited by a nonrandomized patient population, with possible uneven distribution of unrecognized preoperative risk factors between shunt groups. It is a recent study group, and important late outcomes, such as arrhythmia, sudden death, and ventricular dysfunction, might not have yet occurred. Finally, this study might not be powered to evaluate small differences between comparison groups.
The ideal patient awaiting S2R is an infant of reasonable weight with balanced systemic and pulmonary circulation, good ventricular function with minimal AVVR, minimal semilunar valve regurgitation, and good-sized pulmonary arteries. What this study has demonstrated is that there are differences in the ventricular performance by means of echocardiography, coronary perfusion pressure, degree of hypoxemia, amount of pulmonary blood flow by means of hemodynamic evaluation, and pulmonary artery growth between groups of infants who have undergone S1R with either an RV-PA conduit or mBTS. This study did not show that these differences translate into improved outcome for a select shunt strategy. This might be due to no actual difference in outcome between shunt types, the limitation of a nonrandomized patient population, or insufficient numbers of patients to demonstrate a meaningful difference between shunt strategies. The limited, current follow-up data would suggest that infants with an RV-PA conduit at the time of S1R who present with ventricular dysfunction at the time of S2R do not appear to recover function with unloading of the ventricle with S2R. It is unclear whether the long-term outcome of infants undergoing reconstruction with this type of pulmonary blood flow will be better than that currently experienced by infants who underwent S1R with an mBTS. This underscores the need for continued follow-up and critical analysis of data acquired in the ongoing randomized clinical trial of these 2 surgical strategies for the treatment of HLHS.
| Earn CME credits at http://cme.ctsnetjournals.org
|
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  A. C. Polimenakos, S. K. Sathanandam, C. Blair, C. F. el Zein, T. S. Husayni, and M. N. Ilbawi Shunt Reintervention and Time-Related Events After Norwood Operation: Impact of Shunt Strategy Ann. Thorac. Surg., November 1, 2012; 94(5): 1551 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Photiadis, N. Sinzobahamvya, C. Haun, M. Schneider, P. Zartner, E. Schindler, B. Asfour, and V. Hraska Does the shunt type determine mid-term outcome after Norwood operation? Eur J Cardiothorac Surg, August 1, 2012; 42(2): 209 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Frommelt, L. T. Guey, L. L. Minich, M. Bhat, T. J. Bradley, S. D. Colan, G. Ensing, J. Gorentz, H. Heydarian, J. B. John, et al. Does Initial Shunt Type for the Norwood Procedure Affect Echocardiographic Measures of Cardiac Size and Function During Infancy?: The Single Ventricle Reconstruction Trial Circulation, May 29, 2012; 125(21): 2630 - 2638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Petit, C. D. Fraser, R. Mattamal, T. C. Slesnick, C. E. Cephus, and E. C. Ocampo The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1358 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Januszewska, R. Kozlik-Feldmann, R. Dalla-Pozza, S. Greil, J. Abicht, H. Netz, B. Reichart, and E. Malec Right ventricle-to-pulmonary artery shunt related complications after Norwood procedure Eur J Cardiothorac Surg, September 1, 2011; 40(3): 584 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. O'Connor, C. Ravishankar, J. A. Ballweg, M. J. Gillespie, J. W. Gaynor, S. Tabbutt, and T. E. Dominguez Early systemic-to-pulmonary artery shunt intervention in neonates with congenital heart disease J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Fiore, C. Tobin, S. Jureidini, M. Rahimi, E. S. Kim, and K. Schowengerdt A Comparison of the Modified Blalock-Taussig Shunt With the Right Ventricle-to-Pulmonary Artery Conduit Ann. Thorac. Surg., May 1, 2011; 91(5): 1479 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ruffer, F. Arndt, S. Potapov, T. S. Mir, J. Weil, and R. A. Cesnjevar Early Stage 2 Palliation Is Crucial in Patients With a Right-Ventricle-to-Pulmonary-Artery Conduit Ann. Thorac. Surg., March 1, 2011; 91(3): 816 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ballweg, T. E. Dominguez, C. Ravishankar, J. W. Gaynor, S. C. Nicolson, T. L. Spray, and S. Tabbutt A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 537 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Graham, S. C. Zyblewski, J. W. Phillips, G. S. Shirali, S. M. Bradley, G. A. Forbus, V. M. Bandisode, and A. M. Atz Comparison of Norwood Shunt Types: Do the Outcomes Differ 6 Years Later? Ann. Thorac. Surg., July 1, 2010; 90(1): 31 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kaltman, D. B. Andropoulos, P. A. Checchia, J. W. Gaynor, T. M. Hoffman, P. C. Laussen, R. G. Ohye, G. D. Pearson, F. Pigula, J. Tweddell, et al. Report of the Pediatric Heart Network and National Heart, Lung, and Blood Institute Working Group on the Perioperative Management of Congenital Heart Disease Circulation, June 29, 2010; 121(25): 2766 - 2772. [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Hsia, F. Migliavacca, G. Pennati, R. Balossino, G. Dubini, M. R. de Leval, S. M. Bradley, and E. L. Bove Management of a Stenotic Right Ventricle-Pulmonary Artery Shunt Early After the Norwood Procedure Ann. Thorac. Surg., September 1, 2009; 88(3): 830 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Barron, A. Brooks, J. Stickley, S. M. Woolley, O. Stumper, T. J. Jones, and W. J. Brawn The Norwood procedure using a right ventricle-pulmonary artery conduit: Comparison of the right-sided versus left-sided conduit position J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Phelps, W. T. Mahle, D. Kim, J. M. Simsic, P. M. Kirshbom, K. R. Kanter, and K. O. Maher Postoperative Cerebral Oxygenation in Hypoplastic Left Heart Syndrome After the Norwood Procedure Ann. Thorac. Surg., May 1, 2009; 87(5): 1490 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sano, S.-C. Huang, S. Kasahara, K. Yoshizumi, Y. Kotani, and K. Ishino Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt Ann. Thorac. Surg., January 1, 2009; 87(1): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Atallah, I. A. Dinu, A. R. Joffe, C. M.T. Robertson, R. S. Sauve, J. D. Dyck, D. B. Ross, I. M. Rebeyka, and the Western Canadian Complex Pediatric Therapies F Two-Year Survival and Mental and Psychomotor Outcomes After the Norwood Procedure: An Analysis of the Modified Blalock-Taussig Shunt and Right Ventricle-to-Pulmonary Artery Shunt Surgical Eras Circulation, September 30, 2008; 118(14): 1410 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bradley, C. C. Erdem, T.-Y. Hsia, A. M. Atz, V. Bandisode, and J. M. Ringewald Right Ventricle-to-Pulmonary Artery Shunt: Alternative Palliation in Infants With Inadequate Pulmonary Blood Flow Prior to Two-Ventricle Repair Ann. Thorac. Surg., July 1, 2008; 86(1): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
